# Ritalin LA

NDC: 0078-0424
Generic name: methylphenidate hydrochloride
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20020605
Marketing ended: 20261031
FDA application: NDA021284

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0424"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0424
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca